1. Home
  2. HLI vs KRYS Comparison

HLI vs KRYS Comparison

Compare HLI & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Houlihan Lokey Inc.

HLI

Houlihan Lokey Inc.

HOLD

Current Price

$136.55

Market Cap

9.7B

Sector

Finance

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$351.36

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLI
KRYS
Founded
1972
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
9.6B
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
HLI
KRYS
Price
$136.55
$351.36
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
$194.29
$297.60
AVG Volume (30 Days)
640.4K
200.3K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
1.54%
N/A
EPS Growth
6.87
128.00
EPS
1.15
3.62
Revenue
$2,617,516,000.00
$389,130,000.00
Revenue This Year
$13.77
$38.74
Revenue Next Year
$12.10
$32.53
P/E Ratio
$117.63
$96.16
Revenue Growth
9.55
33.94
52 Week Low
$112.83
$145.46
52 Week High
$211.78
$382.54

Technical Indicators

Market Signals
Indicator
HLI
KRYS
Relative Strength Index (RSI) 58.60 48.23
Support Level $133.57 $289.36
Resistance Level $144.92 $382.33
Average True Range (ATR) 3.65 11.24
MACD 0.94 -0.73
Stochastic Oscillator 67.51 28.36

Price Performance

Historical Comparison
HLI
KRYS

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: